Filippo Lodi
Overview
Explore the profile of Filippo Lodi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
648
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Ceci F, Castellucci P, Graziani T, Schiavina R, Brunocilla E, Mazzarotto R, et al.
Eur J Nucl Med Mol Imaging
. 2013 Dec;
41(5):878-86.
PMID: 24346416
Purpose: The aim of this retrospective study was to evaluate the usefulness and the detection rate of (11)C-choline PET/CT in a population of patients with prostate cancer (PC), exclusively treated...
22.
Quarta C, Lodi F, Mazza R, Giannone F, Boschi L, Nanni C, et al.
Mol Metab
. 2013 Sep;
2(3):153-60.
PMID: 24049730
Several lines of evidence suggest that novel pharmacological approaches aimed at converting white adipose tissue (WAT) into brown adipose tissue (BAT) may represent an effective therapeutic strategy for obesity and...
23.
Belosi F, Cicoria G, Lodi F, Malizia C, Fanti S, Boschi S, et al.
Curr Radiopharm
. 2013 Jul;
6(2):72-7.
PMID: 23808765
68Ga labeled radiopharmaceuticals, like 68Ga-DOATNOC and other similar peptides, are gaining relevance in PET-CT, thanks to relatively easy local generator production, that do not requires an installed cyclotron. However, generator...
24.
Boschi S, Malizia C, Lodi F
Recent Results Cancer Res
. 2012 Aug;
194:17-31.
PMID: 22918752
The renaissance of (68)Ga radiopharmacy has led to great advances in automation technology. The availability of a highly efficient, reliable, long-lived (68)Ge/(68)Ga generator system along with a well-established coordination chemistry...
25.
Quarta C, Cantelli E, Nanni C, Ambrosini V, DAmbrosio D, Di Leo K, et al.
Mol Imaging Biol
. 2012 Jul;
15(2):194-202.
PMID: 22777578
Purpose: TH-MYCN transgenic mice represent a valuable preclinical model of neuroblastoma. Current methods to study tumor progression in these mice are inaccurate or invasive, limiting the potential of this murine...
26.
Lodi F, Malizia C, Castellucci P, Cicoria G, Fanti S, Boschi S
Nucl Med Biol
. 2011 Dec;
39(4):447-60.
PMID: 22172394
Positron emission tomography (PET) is a nuclear medicine modality which provides quantitative images of biological processes in vivo at the molecular level. Several PET radiopharmaceuticals labeled with short-lived isotopes such...
27.
Castellucci P, Pou Ucha J, Fuccio C, Rubello D, Ambrosini V, Montini G, et al.
J Nucl Med
. 2011 May;
52(6):886-90.
PMID: 21571796
Unlabelled: The aim of our retrospective study was to assess the incidence of increased uptake of (68)Ga-DOTANOC in the head of the pancreas among a large population of patients with...
28.
Pantaleo M, Mishani E, Nanni C, Landuzzi L, Boschi S, Nicoletti G, et al.
Mol Imaging Biol
. 2010 Apr;
12(6):616-25.
PMID: 20379787
Purpose: The in vivo evaluation of three modified polyethylene glycol (PEG)-anilinoquinazoline derivatives labeled with (124)I, (18)F, and (11)C as potential positron emission tomography (PET) bioprobes for visualizing epidermal growth factor...
29.
Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, Jovine E, et al.
Clin Nucl Med
. 2009 Nov;
34(10):659-65.
PMID: 19893396
Purpose Of The Report: We assessed the usefulness of F-18 fluorodeoxyglucose positron emission tomography (FDG PET) and C-11 acetate PET (AC PET) in distinguishing hepatic lesions due to consequential disease...
30.
Castellucci P, Fuccio C, Nanni C, Santi I, Rizzello A, Lodi F, et al.
J Nucl Med
. 2009 Aug;
50(9):1394-400.
PMID: 19690023
Unlabelled: The purpose of this study was to investigate the effect of total prostate-specific antigen (PSA) at the time of (11)C-choline PET/CT (trigger PSA), PSA velocity (PSAvel), and PSA doubling...